Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells
Glioma is the most common tumor of the central nervous system (CNS), with a 5-year survival rate of <35%. Drug therapy, such as chemotherapeutic and immunotherapeutic agents, remains one of the main treatment modalities for glioma, including temozolomide, doxorubicin, bortezomib, cabazitaxel, dihydr...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
PeerJ Inc.
2023-07-01
|
| Colección: | PeerJ |
| Materias: | |
| Acceso en línea: | https://peerj.com/articles/15571.pdf |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|